| Tocilizumab in COVID-19: factors associated with mortality before and after treatment L Sarabia De Ardanaz, JM Andreu-Ubero, M Navidad-Fuentes, ... Frontiers in Pharmacology 12, 620187, 2021 | 10 | 2021 |
| Reactive arthritis with SARS-COV-2 as a trigger V Ruiz-Del-Valle, LS de Ardanaz, M Navidad-Fuentes, I Martín-Martín, ... Reumatología Clínica (English Edition) 18 (8), 490-492, 2022 | 6 | 2022 |
| Artritis reactiva con SARS-CoV-2 como desencadenante V Ruiz-del-Valle, LS de Ardanaz, M Navidad-Fuentes, I Martín-Martín, ... Reumatología Clínica 18 (8), 490-492, 2022 | | 2022 |
| Effectiveness and safety of tofacitinib in patients with rheumatoid arthritis in conditions of clinical practice L Perez Albaladejo, L Sarabia de Ardanaz, B Nucete Gallego, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 42 (1), 280-280, 2020 | | 2020 |
